Ir para o conteúdo principal

Grafa News and Videos — Page 9

Mais recentes

Grafa
Health

HUTCHMED wins China approval for SYVIK in two blood disorders

HUTCHMED (NASDAQ:HCM) announced that China's National Medical Products Administration (NMPA) approved SYVIK (sovleplenib) for adults with chronic primary immune thrombocytopenia and warm antibody autoimmune hemolytic anemia, marking the company's first internally developed immunology drug approved for commercialization.

Leia mais: HUTCHMED wins China approval for SYVIK in two blood disorders

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas